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LXRa Enhances Lipid Synthesis in SZ95 Sebocytes
Il Hong1, Min-Ho Lee1, Tae-Young Na1, Christos C. Zouboulis2,3 and Mi-Ock Lee1
Differentiation of sebocytes is strongly associated with enhanced lipid synthesis and accumulation in the cells.
Liver X receptors (LXRs) are members of the nuclear receptor superfamily, which play a critical role in
cholesterol homeostasis and lipid metabolism. We examined whether LXRa regulated lipid synthesis in the
immortalized human sebaceous gland cell line SZ95. When the SZ95 sebocytes were treated with the ligand of
LXR such as TO901317 or 22(R)-hydroxycholesterol, lipid droplets were accumulated in the majority of cells
when examined by Oil Red O staining. The expression of the known LXR targets, such as fatty acid synthase and
sterol regulatory-binding protein-1, was induced by TO901317. TO901317 treatment increased expression of
LXRa but not that of LXRb. Transfection of antisense LXRa significantly decreased TO901317-induced target gene
expression and lipid droplet accumulation, suggesting a major role of LXRa in differentiation of sebocytes.
Further, TO901317 decreased the expression of cyclooxygenase-2 and inducible nitric oxide synthase that was
induced by lipopolysaccharide treatment. Together, these results indicate that important roles of LXRa in
differentiation and inflammatory signaling in sebaceous glands. Thus, we suggest that LXR ligands could
provide a new class of therapeutic agents for sebaceous gland-associated disorders such as seborrhea and acne.
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INTRODUCTION
Sebaceous glands secrete an oily substance called sebum that
is made of fat and the debris of dead fat-producing cells in the
skin of mammals. They are found in hair-covered areas where
they are connected to hair follicles to deposit sebum on the
hairs and bring it to the skin surface along the hair shaft. The
structure consisting of hair, hair follicle, and sebaceous
glands are also known as pilosebaceous unit. In the
sebaceous glands, sebum is produced within specialized
cells, which are called sebocytes, and is released as these
cells burst (Zouboulis, 2004). Sebaceous lipogenesis resulting
in accumulation of lipid droplets and subsequent sebum
secretion represents a major step in the terminal differentia-
tion of sebocytes (Kligman, 1963; Downie and Kealey, 1998).
Sebum excretion is associated with the functional main-
tenance of the surface of skin by controlling moisture balance
and providing native immunity (Georgel et al., 2005).
However, excessive sebum production from the sebaceous
glands is one of the major causes of acne (Brown and Shalita,
1998; Zouboulis, 2004).
The growth and differentiation of sebaceous gland are
regulated by several nuclear receptors. For example, andro-
gen receptor is activated by active androgens, such as
dehydroepiandrosterone, androstenedione, and testosterone,
which have been shown to stimulate sebum secretion in
human skin (Fritsch et al., 2001; Zouboulis, 2004). Both
estrogen receptor-a and -b are expressed in the sebaceous
gland; however, estrogen directly opposes the effects of
androgens locally within the sebaceous gland by regulating
genes that negatively influence growth or lipid production of
sebaceous glands (Strauss and Pochi, 1964; Thornton et al.,
2003; Zouboulis, 2004). Expression of peroxisome proli-
ferator-activated receptor (PPAR)g gene plays an important
role in the differentiation of sebocytes, whereas PPARd
finalizes sebocyte maturation and stimulates epidermal lipid
formation (Rosenfield et al., 1999, 2000). Retinoic acid
receptors and retinoid X receptors play different roles in
sebocyte growth and differentiation in that retinoic acid
receptor-b and -g inhibit proliferation and differentiation of
human sebocytes (Tsukada et al., 2000), whereas retinoid
X receptors induce prominent differentiation of sebocytes
isolated from rat preputial glands (Kim et al., 2000).
Liver X receptor (LXR) was identified as an orphan nuclear
receptor that regulates the metabolism of lipid and cholesterol
(Repa and Mangelsdorf, 2000). Two LXR subtypes, LXRa and
LXRb, have been identified. Both LXRa and LXRb form
heterodimers with the retinoid X receptor and bind specific
DNA sequences, that is the LXR response element (LXRE)
(Alberti et al., 2000). LXRa is highly expressed in the
restricted tissues known to play important roles in lipid
metabolism, such as the liver, kidney, small intestine, spleen,
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skeletal muscle, adipose tissue, pituitary, and adrenal gland,
whereas LXRb is expressed ubiquitously (Repa and Mangels-
dorf, 2000; Lu et al., 2001). Both LXRa and LXRb are
expressed in human keratinocytes and fetal rat epidermis,
whereas LXRb is predominantly expressed in mouse epider-
mis (Hanley et al., 2000; Komuves et al., 2002). LXRs are
activated by naturally produced oxysterols, such as 22(R)-
hydroxycholesterol (HC), 24(S)-HC, and 24(S),25-epoxycholes-
terol. They are also activated by synthetic compounds such as
TO901317 and GW683965 (Lehmann et al., 1997; Janowski
et al., 1999; Schultz et al., 2000). LXRs directly control the
expression of sterol regulatory-binding protein-1 (SREBP-1),
which regulates lipogenic enzymes in the liver including fatty
acid synthase (FAS) (Repa et al., 2000; Schultz et al., 2000;
Joseph et al., 2002). Activation of LXRs is also involved in
differentiation of adipocytes, which is generally called adipogene-
sis, through the induction of expression of adipocyte-specific
genes such as PPARg and SREBP-1c. A LXRE motif is present
in the PPARg promoter, on which LXRa/retinoid X receptora
was bound and activated by TO901317 (Seo et al., 2004).
Although many experimental results suggest that the
mechanisms involved in adipogenesis are similarly utilized
for sebocyte differentiation, the role of LXRs has not been
illustrated for sebocytes. Therefore, we studied the role of
LXR in sebaceous lipogenesis and cellular lipid accumula-
tion. We employed the immortalized human sebaceous gland
cell line SZ95, which shows the same characteristics,
morphology, and phenotype as normal human sebocytes
(Zouboulis et al., 1999). We found that activation of LXRa
induces lipid synthesis in sebocytes that was accompanied
with the induction of SREBP-1 and PPARs.
RESULTS
Activation of LXR induces lipid accumulation in the SZ95
sebocytes
To investigate the role of LXR during the differentiation of
sebocytes, we used the SZ95 sebaceous gland cell line which
was established by Simian virus-40 transformation of primary
sebocytes derived from human sebaceous gland (Zouboulis
et al., 1999). When the SZ95 sebocytes were treated with
100mM linoleic acid, large lipid droplets were accumulated in
cytoplasm surrounding nucleus when examined by micro-
scopy after Oil Red O staining (Figure 1a). This result suggests
that the SZ95 sebocytes maintain adequate properties of
sebocytes as described previously (Zouboulis et al., 1999).
Similarly, the synthetic LXR agonist TO901317 induced lipid
accumulation in the SZ95 sebocytes when examined by
microscopy after Oil Red O or Nile red staining (Figure 1a
and b) (Schultz et al., 2000). Consistent with previous
observations, the size of the treated SZ95 sebocytes was
increased (arrows in Figure 1a and b). The enhancement of
intracellular lipids was further measured by flow cytometry
using fluorescence of Nile red-stained cells. As shown in
Figure 1c, linoleic acid treatment made the histogram shift,
indicating increased intracellular lipid. Treatment with
TO901317 and with 22(R)-HC, a natural ligand of LXR, also
increased Nile red staining of the cells, consistent with the
results of microscopic examination.
Expression of SREBP and FAS is induced in response to LXRa
activation
The activation of LXRs significantly increases the expression
of lipogenic genes such as FAS and SREBP-1 during
adipogenesis (Seo et al., 2004). Therefore, we examined
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Figure 1. TO901317 induces lipid synthesis in the SZ95 sebocytes. (a) The
SZ95 sebocytes were treated with vehicle (upper left panel), 100 mM linoleic
acid (upper right panel), or 1 mM TO901317 (lower left panel) for 48 hours.
Also, 1 mM 9-cis-RA was co-treated with 1 mM TO901317 (lower right panel).
At the end of treatment, lipid droplets in the SZ95 sebocytes were stained by
Oil Red O and examined by a light microscope. Bar¼ 50 mm. (b) The SZ95
sebocytes were treated with vehicle (left panel) or 1 mM TO901317 (right
panel) for 48 hours. Lipid droplets in cells were stained by Nile red and
examined by a fluorescence microscope using a 530–550nm bandpass
exciter filter by light emission of 4575nm. Bar¼ 50mm. (c) The SZ95
sebocytes were treated with vehicle (green), 10 mM 22(R)-HC (purple), 1 mM
TO901317 (blue), or 100 mM linoleic acid (black). The histogram obtained
with sebocytes without staining was filled with red. Flow cytometry was
performed after cells were stained with Nile red. Fluorescence was measured
by a 580730 nm band pass filter. One representative of at least three
independent experiments with similar results is shown.
www.jidonline.org 1267
Il Hong et al.
LXRa Regulates Lipid Metabolism in SZ95
whether these genes are also involved in the lipid synthesis in
the SZ95 sebocytes. When the SZ95 sebocytes were treated
with TO901317, the level of LXRa protein was increased in a
time-dependent manner. Induction was observed as early as
12 hours after treatment and it was continued up to 48 hours
(Figure 2a). LXRb protein was expressed, but its expression
level was not altered by TO901317 treatment. Consistent
with the induction of LXRa, the expression of SREBP-1 was
increased. The transcript level of LXRa, but not that of LXRb,
was increased suggesting that LXRa may be the major LXR
subtype that responds to TO901317 in the SZ95 sebocytes.
mRNA levels of SREBP-1c and FAS were increased after
TO901317 treatment, indicating that the induction of these
genes expression was occurred at transcription level which
may include transcriptional activation and/or blocking
of mRNA degradation (Figure 2b). The transcriptional
activity of LXRa in the SZ95 sebocytes was further confirmed
by the reporter gene analysis using a reporter containing
the LXRE. As shown in Figure 3a, the reporter activity
was increased approximately threefold following TO901317
treatment. When the plasmid encoding LXRa was
co-transfected, the level of induction was approximately
20-fold. In contrast, transfection of LXRb induced only
3.5-fold activation of the reporter. To further distinguish
the role of LXR subtypes, we employed the plasmid
encoding antisense (AS) LXRa. When the expression of
LXRa was repressed by AS-LXRa, the induction of
SREBP-1 protein was abolished (Figure 3b). Similarly, the
lipid droplet accumulation induced by TO901317 was
largely decreased in the SZ95 cells (Figure 3c). These
results indicate a major role of LXRa in differentiation of
sebocytes.
Induction of PPARs by TO901317 treatment in the SZ95
sebocytes
It has been reported that PPARs play an important role in
normal physiology of the skin and that all PPAR isotypes are
expressed in human sebaceous glands and in the SZ95
sebocytes in vitro (Chen et al., 2003; Alestas et al., 2006).
Recently, Seo et al. (2004) reported that a cross-talk between
LXR and PPAR regulates fatty acid metabolism and the
differentiation of adipocytes. Therefore, we checked whether
PPARs were involved in the LXR-induced lipid metabolism in
the SZ95 sebocytes. As with normal adipocytes, the protein
levels of all PPAR isotypes were increased in the SZ95
sebocytes following TO901317 treatment. An induction of
PPARd appeared 12 hours after treatment and that of PPARa
and PPARg was observed after 24 hours of treatment (Figure
4a). Consistent with the protein levels, the transcript levels of
PPARd and PPARg were induced in a similar pattern,
indicating that the induction was regulated during transcrip-
tion (Figure 4b). Next, we examined the expression of
downstream target genes of PPARg, such as acyl Coenzyme
A synthetase and phosphoenolpyruvate carboxykinase-2.
Consistent with the induction of PPARs, the transcript levels
of acyl Coenzyme A synthetase-2 and PEPCK-2 were also
increased (Figure 4b).
Inhibition of the expression of proinflammatory genes
by TO901317 treatment
Ligands of PPARa, PPARd, and LXRa were reported
to alleviate cutaneous inflammation in a mouse model of
irritant or allergic contact dermatitis (Sheu et al., 2002;
Fowler et al., 2003; Schmuth et al., 2004). Therefore, we
tested the expression of inflammatory genes, such as
cyclooxygenase-2 (COX-2) and inducible nitric oxide
synthase (iNOS), in the SZ95 sebocytes after TO901317
treatment. When the SZ95 sebocytes were treated with
lipopolysaccharide, the expression of COX-2 and iNOS was
largely increased. By contrast, TO901317 treatment de-
creased the lipopolysaccharide-induced expression of these
genes (Figure 5).
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Figure 2. TO901317 induces the expression of LXRa and its downstream
target genes in the SZ95 sebocytes. The SZ95 sebocytes were treated with
1mM TO901317 for the indicated time periods. (a) The expression of LXRa,
LXRb, and SREBP-1 (65 kDa) proteins was analyzed by western blot analysis
using specific antibodies. The expression of a-tubulin was monitored as a
control. One representative of at least three independent experiments with
similar results is shown (upper panel). The density of the indicated protein
band was determined using an image analysis system. The value was
normalized to that of a-tubulin and expressed as fold induction relative to
vehicle treatment. Data shown are the mean7SD of three independent
experiments (lower panel) (*Po0.05; **Po0.01). (b) The expression of LXRa,
LXRb, SREBP-1c, and FAS transcripts was analyzed by real-time PCR. Data
shown are the mean7SD of three independent experiments (*Po0.05;
**Po0.01; ***Po0.001).
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DISCUSSION
Sebaceous lipogenesis, leading to accumulation of lipid
droplets and finally to sebum secretion, represents a major
step of the differentiation process in sebaceous gland cells
(Zouboulis et al., 1994; Downie and Kealey, 1998; Zouboulis,
2004). During the last decade, considerable progress has
been made in our understanding of the molecular events
regulating lipogenesis in adipose tissues and the liver. Several
transcriptional factors have been identified, which act
cooperatively and sequentially trigger lipogenesis steps in
pre-adipocytes. Among them, CCAAT/enhancer binding
proteins, PPAR and SREBP-1, are thought to play crucial
roles in adipogenesis (Wu et al., 1999; Rosen et al., 2000).
LXRa is highly expressed in tissues known to play important
roles in lipid metabolism, such as the liver, kidney, small
intestine, spleen, skeletal muscle, and adipose tissue (Repa
and Mangelsdorf, 2000; Lu et al., 2001). Here, we demons-
trated that both LXRa and LXRb were expressed in the SZ95
sebocytes and that LXRa plays a critical role in sebaceous
lipid production.
LXR ligands activated the expression of all three subtypes
of PPARs and downstream target genes indicating that PPARs
may mediate the lipogenic function of LXRa in sebocytes, at
least in part. These data have currently been confirmed by a
preliminary independent report indicating that both LXR
isotypes are expressed in the SZ95 sebocytes and that LXRa
agonists simulate lipogenesis and inhibit proliferation of the
SZ95 sebocytes (Russell et al., 2006). It has further been
reported that activation of LXR involves the induction of
PPARg and downstream adipogenic gene expression in
adipose tissue (Seo et al., 2004). PPAR subtypes have been
well investigated in the skin because of their distribution and
their roles in regulating lipid metabolism and the differentia-
tion of epidermis (Hanley et al., 1997; Rosenfield et al.,
2000). PPARa protein is normally expressed predominantly in
the epidermis, whereas PPARg and PPARa protein are almost
equally expressed in the sebocytes (Rosenfield et al., 2000).
However, the expression pattern may change (see Russell
et al., 2006) during hyperplasia, differentiation, and inflam-
mation (Alestas et al., 2006). Gene disruption studies in mice
indicated that PPARa mediates skin barrier function, PPARb
improves inflammatory responses in the skin, and that PPARg
is required for differentiation of sebocytes (Rosenfield et al.,
1999). In human skin, both PPARa and PPARg can modify
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Figure 3. LXRa mediates the response of the SZ95 sebocytes to TO901317. (a) The SZ95 sebocytes were transfected with 1 mg LXRE-Luc in the absence
or presence of 20 ng pCMX-LXRa or pCMX-LXRb. After 24 hours of transfection, cells were treated with vehicle or with the indicated concentration of
TO901317 for 24 hours. At the end of treatment, cell lysates were obtained and analyzed. Data shown are the mean7SD of three independent determinations
(*Po0.05; **Po0.01; ***Po0.001). (b) The SZ95 sebocytes were transfected with 3 mg each p3XFLAG7.1-AS-LXRa (AS-LXRa) or empty vector (EV). After
24 hours of transfection, cells were treated with or without 1 mM TO901317 for 24 hours. At the end of treatment, the expression of LXRa, LXRb, and SREBP-1
was analyzed by western blot analysis. One representative of three independent experiments with similar results is shown (left panel). The density of the
indicated protein band was determined using an image analysis system. The value was normalized to that of a-tubulin and expressed as fold induction relative to
no treatment. Data shown are the mean7SD of three independent experiments (right panel) (*Po0.05; ***Po0.001). (c) The SZ95 sebocytes were transfected
with 2 mg each empty vector (upper panel) or p3XFLAG7.1-AS-LXRa (lower panel). After 24 hours of transfection, cells were treated with (right panel) or
without (left panel) 1mM TO901317 for 48 hours. At the end of treatment, lipid droplets in the SZ95 sebocytes were examined by a light microscope.
Bar¼50 mm. One representative of at least three independent experiments with similar results is shown.
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sebocyte differentiation (Trivedi et al., 2006). Because
sebocytes contain large amount of cholesterol and its
derivatives (Zouboulis et al., 1999; Thiboutot et al., 2003),
they may use this class of lipids as natural ligands for LXR,
which leads to the activation of PPARs. Further studies are
required to determine the relative contribution of the PPAR
pathway in LXR-induced lipogenesis in sebocytes.
Activation of LXR by TO901317 inhibited the expression
of the proinflammatory factors, COX-2 and iNOS, in the SZ95
sebocytes. The results were consistent with the previous
observation that the LXR pathway antagonizes inflammatory
gene expression and reduces inflammatory lesion in a mouse
model of contact dermatitis (Fowler et al., 2003). The
expression of COX-2 and iNOS was largely controlled by
NF-kB in response to a variety of inflammatory signals
(Hayden and Ghosh, 2004; Zelcer and Tontonoz, 2006),
suggesting that LXRa may antagonize activation of NF-kB in
sebocytes. Recently, we have reported that COX-2 is
normally expressed in the SZ95 sebocytes, and COX-2
expression is upregulated in the sebaceous glands of acne-
involved skin (Alestas et al., 2006; Zhang et al., 2006). The
elevation of COX-2 may be caused by activation of PPARs as
inflammatory lipid metabolites such as 15-deoxy D12,14-
prostaglandin J2 and leukotriene B4 are natural ligands for
PPAR. Further, UVB-induced COX-2 expression was shown
to be PPARg-dependent in the SZ95 sebocytes (Zhang et al.,
2006). These results are in contrast to the known anti-
inflammatory function of PPARg in macrophages, in which
PPARg agonists antagonized inflammatory responses by
transrepression of NF-kB target genes (Ricote et al., 1998).
Therefore, we speculate that the repression of COX-2 and
iNOS levels might be PPARg-independent and unique for
LXR-induced anti-inflammatory function in sebocytes. Future
investigations using knockdown strategy would help to clarify
the role of LXRa in inflammation processes of sebocytes as
well as sebaceous glands.
Excess sebum and inflammation, been currently accused
to initiate acne lesions (Zouboulis et al., 2005), are associated
with the function of LXRa, indicating that LXRa could be one
of the most important therapeutic targets for the treatment
of acne. Thus, it would be advantageous to develop
selective LXR agonists and antagonists to regulate sebaceous
lipogenesis and inflammation. A better understanding of
the molecular control of the LXR-induced sebocyte
differentiation and inflammation may lead to improved
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pharmacological interventions for the treatment of sebaceous
gland-associated disorders.
MATERIALS AND METHODS
Cells and reagents
The immortalized human sebocyte cell line SZ95 was maintained in
DMEM/Ham’s F12 medium (1:1) containing 10% heat-inactivated
fetal bovine serum (Hyclone, Road Logan, UT), 1% penicillin
streptomycin (Gibco BRL, Grand Island, NY), and 5 ngml1 human
epidermal growth factor (Sigma, St Louis, MO; Zouboulis et al.,
1999). Cultures were maintained in humidified atmosphere of 5%
CO2 at 371C, and medium was replaced every 2–3 days. TO901317
was purchased from Alexis Biochemicals (San Diego, CA). Linoleic
acid and 22(R)-HC were obtained from Sigma. Stock solutions were
made in dimethylsulfoxide/ethanol (1:1) (vol/vol) and maintained at
201C. Further dilutions were made in culture medium before use.
The study was conducted under the approval of the medical ethical
committee of Seoul National University.
Oil red O staining of intracellular lipids
The SZ95 sebocytes were seeded (3 104 cells per well) on 12-well
culture plates, incubated overnight, and then treated with 100 mM
linoleic acid or 1 mM TO901317 for 48 hours. Cells that were treated
with vehicle served as control. At the end of treatment, cells were
washed with phosphate-buffered saline (PBS), fixed in 4% formal-
dehyde for 5minutes. Fixed cells were stained with the Oil Red O
solution, a mixture of 1% Oil Red O (Sigma) and dH2O in a ratio of
6:4 (vol/vol), for 15minutes, and washed with PBS (Zouboulis et al.,
1999). Stained cells were visualized by microscopy.
Nile red staining and flow cytometry
A stock solution of Nile red, 1mgml1 in acetone, was diluted to the
final concentration of 1mgml1 in PBS. Cells were fixed in 4%
formaldehyde for 5minutes, stained with Nile red solution for
15minutes, and washed with PBS (Zouboulis et al., 1999; Chen
et al., 2003). Stained cells were visualized by fluorescence
microscopy. For flow cytometry, cells were detached from flask,
resuspended in complete medium, and centrifuged at 250 g for
10minutes. Cell pellets were then resuspended in PBS and stained
with Nile red solution for 1minute. Fluorescence intensity was
measured by a FACcalibur (Becton Dickson, Plymouth, UK). Nile
red fluorescence was collected through a 580730 nm bandpass
filter, which measures neutral lipid and phospholipids.
Transient transfection experiments
The LXRE-Luc reporter and expression vectors for LXRa and LXRb
were kindly provided by Dr J Lee (Baylor University, Huston, TX)
(Kim et al., 2003). The AS-LXRa was constructed by inserting the full-
length LXRa, a KpnI/NotI fragment of pCMX-LXRa, and in reverse
orientation into the p3XFLAGTM7.1 (Sigma). For reporter gene assays,
the SZ95 sebocytes (1 105 cells per well) were seeded in 12-well
culture plates and incubated overnight. Cells were transfected with
1mg LXRE-luc reporter plasmid and 0.2mg b-galactosidase expres-
sion vector with or without 20 ng receptor expression vector using
LipofectaminePlus (Invitrogen, Carlsbad, CA). At the end of
treatment, cells were lysed and luciferase activity was determined
using an analytical luminescence luminometer. Luciferase activity
was normalized for transfection efficiency by the corresponding
b-galactosidase activity. For transient expression of AS-LXRa,
sebocytes (8 105 cells per well) were seeded in six-well culture
plates and incubated overnight. The cells were transfected with 3mg
plasmid using WelFect-EXPLUS (WelGENE Inc., Daegu, Korea).
Western blot analysis
Western blot analysis was performed as described previously (Yoo
et al., 2006) using specific primary antibodies against LXRa, PPARa,
PPARd, PPARg, iNOS (Santa Cruz Biotechnology, Santa Cruz, CA),
COX-2 (Cayman, Ann Arbor, MI), and LXRb (Affinity BioReagents,
Golden, CO). Antibodies against SREBP-1 were kindly provided by
Dr KS Kim at Yonsei University College of Medicine (Im et al., 2005).
Secondary antibodies conjugated with horseradish peroxidase
(Zymed Lab, San Francisco, CA) were used and immunoreactive
proteins were detected using the Western Blotting Luminol Reagent
(Santa Cruz Biotechnology).
Real-time PCR analysis
Total RNA was prepared using the Qiagen RNeasy kit (Qiagen,
Chatworth, CA) and reverse transcribed by Moloney murine
leukemia virus reverse transcriptase (Gibco BRL). Gene-specific
primers were designed using Oligo 6.0 software (Molecular Biology
Insights, Cascade, CO). Real-time PCR amplifications were per-
formed using Fast Start DNA Master SYBR Green I Mixture Kit
(Roche Diagnostics, Germany) in a Light Cycler system (Roche
Diagnostics) following the manufacturer’s protocol. To determine
the specificity of amplification, melting curve analysis was applied to
all final PCR products. The Cp value was normalized to that of
b-actin and expressed as fold induction relative to vehicle treatment.
Statistical analysis
Experimental values were expressed as mean7SD. The significance
of differences was determined by Student’s t-test and expressed as a
probability value. Mean differences were considered to be signi-
ficant when Po0.05.
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